“Getting diagnosed with multiple sclerosis, at first you feel your health is being taken from you,” Kayla Schneider said Monday.

A newly FDA-approved drug tested at the University of Cincinnati is helping her take it back.

Multiple sclerosis is a disease in which the body’s natural defenses begin attacking its central nervous system, potentially causing a wide range of physical and mental symptoms that can cause lifelong disability and even death.

For Schneider, those symptoms included pain behind her eyes and a partial loss of vision. She began researching her condition in hopes of locating a solution, which is when she learned about Ocrevus.

UC Health helped complete a study of the drug, which Dr. Aram Zabeti said is one of a wide variety of treatments available for people with multiple sclerosis.

Read the full article here